Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Moderna says booster dose of its COVID-19 vaccine appears protective against Omicron
The company still plans to develop a vaccine specifically to protect against Omicron, which it hopes to advance into clinical…
WHO grants Emergency Use Listing for Novavax and SII’s COVID-19 vaccine
According to WHO, Covovax was assessed under its emergency use listing procedure based on the review of data on quality, safety…
UK researchers developing new COVID-19 vaccines
The research project will boost the UK’s and the world’s ability to rapidly develop new vaccines in response to new variants of…
Centre working on policy to encourage research in pharma sector: Mansukh Mandaviya
The day-long pre-event summit on 'Holistic Healthcare: Focus on Pharmaceuticals and Medical Devices' included deliberations on…
Cipla receives USFDA nod to market Lanreotide injection in US market
The company said it has received final approval for Lanreotide Injection from the US Food and Drug Administration (FDA)
People should know what they want to achieve
Suneela Thatte, VP and Head – R&D, India, Merck KGaA, in an interaction with Ashwini Prakash, Managing Partner India, Asia…
Hazards of self-medication and urgent need for regulation
Advocate Satya Muley, practising at Bombay High Court, sheds light on the problems caused due to self-medication and the rise in…
Panel Discussion: Biologics and Biosimilars: Challenges and opportunities in FDD
FDD Conclave 2021 | Day 2 | 17th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Panel Discussion: Oral solid dosage forms: Trends and opportunities
FDD Conclave 2021 | Day 2 | 17th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference
Session by Arjun Singh Dasoondi, AVP, Amway
FDD Conclave 2021 | Day 2 | 17th December 2021 | 2:00 PM - 6:00 PM IST | Virtual Conference